Shandong Weigao Group Medical Polymer Company Ltd (1066)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Shandong Weigao Group Medical Polymer Company Ltd (1066) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011936
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shandong Weigao Group Medical Polymer Company Ltd (Weigao) researches, develops, manufactures and sells disposable medical consumables, orthopedic materials and blood purification products. Its products include infusion sets, needles, blood bags, heart eluting stents, blood sampling products and PVC granules. The company’s trauma and spinal orthopedic materials and tools include steel plates, screws, spinal series consumables; and artificial joint consumables, which are currently under development. Weigao’s medical needle products include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles. The company offers these products to its customers through healthcare organizations and distributors, hospitals, blood stations, medical units and trading companies. Weigao is headquartered in Weihai, China.

Shandong Weigao Group Medical Polymer Company Ltd (1066) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Misonix Enters into Distribution Agreement with Shandong Weigao Orthopedic Device 10
Terumo Enters Into Joint Venture Agreement With Shandong Weigao Group 11
Equity Offering 12
Nikkiso to Acquire 5% Stake in Weihai Weigao Blood Purification Products for USD15 Million 12
Shandong Weigao Group Medical Polymer Plans to Spin Off Shandong Weigao Orthopedic Device 13
Shandong Weigao Orthopedic Device Files Preliminary Prospectus for IPO for USD38.7 Million 14
Weiha Weigao Blood to Raise USD78 Million in Private Placement of Shares 15
Shandong Weigao Group Medical Polymer Raises USD224 Million in Private Placement of Shares 16
Shandong Weigao Group Medical Announces Public Offering Of US$227 Million 17
Acquisition 18
Shandong Weigao Group Medical Polymer Bids to Acquire US Medical Device Company 18
Shandong Weigao Group Medical Polymer Sells its Stake in Shandong Weigao Orthopedic for up to USD47 Million 19
CB Medical Holdings Completes Acquisition Of 21.7% Stake In Biosensors International For US$312.2 Million 20
Biosensors Completes Acquisition Of Remaining 50% Interest In JW Medical Systems From Shandong Weigao Group 21
Shandong Weigao Group Medical Polymer Company Ltd – Key Competitors 23
Shandong Weigao Group Medical Polymer Company Ltd – Key Employees 24
Shandong Weigao Group Medical Polymer Company Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Key Facts, 2016 2
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Shandong Weigao Group Medical Polymer Company Ltd, Deals By Market, 2011 to YTD 2017 8
Shandong Weigao Group Medical Polymer Company Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Misonix Enters into Distribution Agreement with Shandong Weigao Orthopedic Device 10
Terumo Enters Into Joint Venture Agreement With Shandong Weigao Group 11
Nikkiso to Acquire 5% Stake in Weihai Weigao Blood Purification Products for USD15 Million 12
Shandong Weigao Group Medical Polymer Plans to Spin Off Shandong Weigao Orthopedic Device 13
Shandong Weigao Orthopedic Device Files Preliminary Prospectus for IPO for USD38.7 Million 14
Weiha Weigao Blood to Raise USD78 Million in Private Placement of Shares 15
Shandong Weigao Group Medical Polymer Raises USD224 Million in Private Placement of Shares 16
Shandong Weigao Group Medical Announces Public Offering Of US$227 Million 17
Shandong Weigao Group Medical Polymer Bids to Acquire US Medical Device Company 18
Shandong Weigao Group Medical Polymer Sells its Stake in Shandong Weigao Orthopedic for up to USD47 Million 19
CB Medical Holdings Completes Acquisition Of 21.7% Stake In Biosensors International For US$312.2 Million 20
Biosensors Completes Acquisition Of Remaining 50% Interest In JW Medical Systems From Shandong Weigao Group 21
Shandong Weigao Group Medical Polymer Company Ltd, Key Competitors 23
Shandong Weigao Group Medical Polymer Company Ltd, Key Employees 24
Shandong Weigao Group Medical Polymer Company Ltd, Other Locations 25
Shandong Weigao Group Medical Polymer Company Ltd, Subsidiaries 25

★海外企業調査レポート[Shandong Weigao Group Medical Polymer Company Ltd (1066)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sysmex Inostics GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Inostics GmbH (Sysmex Inostics), formerly Inostics GmbH, a subsidiary of Sysmex Corp, is a molecular diagnostics company that offers blood-based cell-free tumor treatment solutions. The company offers services such as clinical trials, research and development, and testing for physicia …
  • Vale SA:企業の戦略・SWOT・財務情報
    Vale SA - Strategy, SWOT and Corporate Finance Report Summary Vale SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Colonial Group Inc.:企業の戦略・SWOT・財務分析
    Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report Summary Colonial Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MLM Biologics Inc:製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for wounds such as chronic vascular ulcers, draining wounds, partial an …
  • Salvatore Ferragamo SpA (SFER):企業の財務・戦略的SWOT分析
    Salvatore Ferragamo SpA (SFER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Getlink SE (GET):企業の財務・戦略的SWOT分析
    Getlink SE (GET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zara Investment (Holding) Co Ltd:戦略・SWOT・企業財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Symbolic Displays, Inc.:企業の戦略・SWOT・財務情報
    Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report Summary Symbolic Displays, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Tupperware Brands Corporation:企業の戦略・SWOT・財務分析
    Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report Summary Tupperware Brands Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Merz Aesthetics Inc:企業の戦略的SWOT分析
    Merz Aesthetics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bioneer Corp (064550):企業の財務・戦略的SWOT分析
    Bioneer Corp (064550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shree Renuka Sugars Ltd (RENUKA):企業の財務・戦略的SWOT分析
    Shree Renuka Sugars Ltd (RENUKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tokyo Gas Co., Ltd.:企業の戦略・SWOT・財務分析
    Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Albireo Pharma Inc (ALBO):医療機器:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Marsh & McLennan Companies, Inc.:企業の戦略・SWOT・財務情報
    Marsh & McLennan Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Marsh & McLennan Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • mAbxience SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Mabxience SA (mAbxience), a subsidiary of Chemo Espana SA, is a biotechnology company that research, develops and manufactures biosimilar monoclonal antibodies. The company develops biosimilars, which are used for the treatment and prevention of various diseases in onclology such as breast c …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • OpGen Inc (OPGN)-製薬・医療分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • McAlister’s Corporation:企業の戦略・SWOT・財務情報
    McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report Summary McAlister’s Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆